Alumis (ALMS) Other Non Operating Income (2023 - 2025)

Alumis (ALMS) reported Other Non Operating Income of -$54000.0 for Q3 2025, down 35.0% year-over-year from -$83076.9 in Q3 2024, and down 42.11% quarter-over-quarter from -$38000.0 in Q2 2025.

Alumis (ALMS) Other Non Operating Income (2023 - 2025) Analysis & Trends

Alumis (ALMS) has 3 years of Other Non Operating Income data on file, last reported at -$54000.0 in Q3 2025.

  • Other Non Operating Income for Q3 2025 came in at -$54000.0, down 35.0% year-over-year; the trailing twelve-month figure through Dec 2025 was -$136000.0 (up 94.25% YoY), and the FY2025 annual result was $187.9 million, up 3575.9% from the prior year.
  • Other Non Operating Income slipped to -$54000.0 in Q3 2025 per ALMS's latest filing, from -$38000.0 in the prior quarter.
  • Over five years, Other Non Operating Income peaked at $432000.0 in Q2 2023 and troughed at -$2.3 million in Q2 2024.
  • A 3-year average of -$327625.0 and a median of -$42000.0 in 2024 frame the typical range for Other Non Operating Income.
  • The sharpest annual moves came in 2024 and 2025: Other Non Operating Income plunged 634.95% in 2024, then jumped 98.36% in 2025.
  • A 3-year view of Other Non Operating Income shows it stood at -$551000.0 in 2023, then surged by 92.74% to -$40000.0 in 2024, then tumbled by 35.0% to -$54000.0 in 2025.
  • Business Quant data shows ALMS's Other Non Operating Income at -$54000.0 in Q3 2025, -$38000.0 in Q2 2025, and -$44000.0 in Q1 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 Alumis 1.99 Bn 1.90 Bn -

Historic Data

Download Data
DateValue
Sep 30, 2025 -54,000.00
Jun 30, 2025 -38,000.00
Mar 31, 2025 -44,000.00
Sep 30, 2024 -40,000.00
Jun 30, 2024 -2.31 Mn
Mar 31, 2024 -15,000.00
Sep 30, 2023 -551,000.00
Jun 30, 2023 432,000.00